We are live on ! Find out more

2,990 hedge funds and large institutions have $163B invested in Merck in 2022 Q3 according to their latest regulatory filings, with 121 funds opening new positions, 1,374 increasing their positions, 1,114 reducing their positions, and 104 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more call options, than puts

Call options by funds: $2.42B | Put options by funds: $1.79B

23% more repeat investments, than reductions

Existing positions increased: 1,374 | Existing positions reduced: 1,114

16% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 104

0.78% more ownership

Funds ownership: 74.29%75.08% (+0.78%)

1% less funds holding

Funds holding: 3,0142,990 (-24)

4% less capital invested

Capital invested by funds: $171B → $163B (-$7.45B)

6% less funds holding in top 10

Funds holding in top 10: 238224 (-14)

Holders
2,990
Holders Change
-24
Holders Change %
-0.8%
% of All Funds
51.5%
Holding in Top 10
224
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.88%
% of All Funds
3.86%
New
121
Increased
1,374
Reduced
1,114
Closed
104
Calls
$2.42B
Puts
$1.79B
Net Calls
+$627M
Net Calls Change
+$85.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Acadian Asset Management
251
Acadian Asset Management
Massachusetts
$53.6M -$7.95M -89,035 -13%
CF
252
Cantor Fitzgerald
New York
$53.4M +$5.96M +66,758 +12%
BHIA
253
Birch Hill Investment Advisors
Massachusetts
$52.8M -$5M -56,022 -8%
MAMU
254
Marathon Asset Management (UK)
United Kingdom
$52.3M -$45.9M -513,682 -46%
UH
255
Unigestion Holding
Switzerland
$51.7M +$12.4M +139,416 +30%
AAM
256
Ardevora Asset Management
United Kingdom
$51.6M -$839K -9,400 -2%
FAF
257
Första AP-fonden
Sweden
$51.3M -$3.6M -40,300 -6%
Point72 Asset Management
258
Point72 Asset Management
Connecticut
$51.2M -$53.7M -601,600 -50%
RCM
259
Radnor Capital Management
Pennsylvania
$51.2M +$25.1K +281 +0%
Qube Research & Technologies (QRT)
260
Qube Research & Technologies (QRT)
United Kingdom
$50.4M -$44.3M -495,887 -46%
SI
261
Sofinnova Investments
California
$50.2M +$19.9M +222,507 +62%
SCM
262
Shapiro Capital Management
Georgia
$49.4M -$33.6M -376,652 -40%
CIM
263
CCLA Investment Management
United Kingdom
$49.4M +$51.2M +573,187 New
DLA
264
Douglas Lane & Associates
New York
$49M -$348K -3,902 -0.7%
NPA
265
Nichols & Pratt Advisers
Massachusetts
$49M -$597K -6,688 -1%
KCM
266
Kornitzer Capital Management
Kansas
$49M -$750K -8,404 -1%
MME
267
Meag Munich Ergo
Germany
$48.5M +$6.61M +74,085 +15%
BFS
268
Bradley Foster & Sargent
Connecticut
$48.4M +$53K +594 +0.1%
BS
269
Banco Santander
Spain
$47.8M +$1.73M +19,420 +4%
TCM
270
Tekla Capital Management
Massachusetts
$47.5M
AIM
271
Artemis Investment Management
United Kingdom
$47.2M -$3.46M -38,777 -7%
LBA
272
Letko, Brosseau & Associates
Quebec, Canada
$46.9M -$818K -9,168 -2%
Impax Asset Management Group
273
Impax Asset Management Group
United Kingdom
$46.8M -$107K -1,197 -0.2%
NC
274
Nicholas Company
Wisconsin
$46.5M -$17K -190 -0%
MNG
275
Manning & Napier Group
New York
$46.1M -$882K -9,885 -2%

MRK Hedge Fund Activity: Q3 2022 in Review

2,990 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2022, worth a combined $163B — down 4.4% from $171B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new MRK positions and 104 closed out — a net gain of 17 holders — while 1,374 added to existing stakes and 1,114 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $1.47B. The largest seller was Marshall Wace, cutting an estimated $459M.

  • 2,990 institutional investors held Merck (MRK) as of Q3 2022, down from 3,014 in Q2 2022.
  • Funds reported $163B of Merck stock for Q3 2022, down 4.4% quarter-over-quarter.
  • 121 funds opened new Merck positions in Q3 2022 and 104 closed out, a net change of +17 holders.
  • The largest Merck buyer in Q3 2022 was Janus Henderson Group, an estimated $1.47B added.
  • The largest Merck seller in Q3 2022 was Marshall Wace, an estimated $459M sold.

Based on aggregated 13F filings for Q3 2022.